ARDELYX INC. - COMMON STOCK

NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK

09 Jan 2024 09:45:32 By NetDania Notify

NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK

08 Jan 2024 09:45:43 By NetDania Notify

Ardelyx Provides Update on Growing Commercial Momentum and 2024 Strategic Priorities

08 Jan 2024 08:00:00 By Nasdaq GlobeNewswire

Ardelyx to Provide Company Update on IBSRELA® and Host a KOL Discussion on the IBS-C Landscape on Monday, January 8

03 Jan 2024 08:03:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK

20 Dec 2023 09:45:03 By NetDania Notify

Ardelyx, Inc. Reports Employment Inducement Grants

20 Dec 2023 08:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK

19 Dec 2023 09:46:12 By NetDania Notify

NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK

18 Dec 2023 09:45:08 By NetDania Notify

NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK

15 Dec 2023 09:45:15 By NetDania Notify

NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK

14 Dec 2023 09:45:03 By NetDania Notify

NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK

13 Dec 2023 09:47:25 By NetDania Notify

NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK

07 Dec 2023 09:45:06 By NetDania Notify

NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK

06 Dec 2023 12:28:31 By NetDania Notify

Ardelyx, Inc. Reports Employment Inducement Grants

21 Nov 2023 16:02:00 By Nasdaq GlobeNewswire

Ardelyx to Participate at the Piper Sandler 35th Annual Healthcare Conference

21 Nov 2023 08:01:45 By Nasdaq GlobeNewswire

XPHOZAH® (tenapanor) Granted Orphan Drug Designation by U.S. FDA for the Treatment of Pediatric Hyperphosphatemia

15 Nov 2023 16:02:00 By Nasdaq GlobeNewswire

Ardelyx Announces Departure of Board Member

13 Nov 2023 16:02:00 By Nasdaq GlobeNewswire

Ardelyx to Participate at the Jefferies London Healthcare Conference

10 Nov 2023 08:05:00 By Nasdaq GlobeNewswire

Ardelyx Announces XPHOZAH® (tenapanor) Now Available in the United States

06 Nov 2023 08:00:00 By Nasdaq GlobeNewswire

Ardelyx Shares Positive Data from Studies of XPHOZAH® (tenapanor), a First-in-Class Phosphate Absorption Inhibitor, at ASN Kidney Week 2023

03 Nov 2023 08:00:00 By Nasdaq GlobeNewswire